For research use only. Not for therapeutic Use.
Blontuvetmab (AT 004)is a caninized CD20 monoclonal antibody. Blontuvetmab can be used for the research of Canine B-cell lymphoma[1].
Catalog Number | I042154 |
CAS Number | 1608112-78-2 |
Purity | ≥95% |
Reference | [1]. Mizuno T, et, al. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Sci Rep. 2020 Jul 10;10(1):11476. |